Stay updated on ADXS31-142 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the ADXS31-142 in mCRPC Clinical Trial page.

Latest updates to the ADXS31-142 in mCRPC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of a clinical study involving ADXS31-142 and pembrolizumab, while adding a new identifier for the study and a revision number update.SummaryDifference26%
- Check69 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check112 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to ADXS31-142 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS31-142 in mCRPC Clinical Trial page.